Last reviewed · How we verify
FRAME-001 personalized vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
FRAME-001 personalized vaccine (FRAME-001 personalized vaccine) — Frame Pharmaceuticals B.V..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| FRAME-001 personalized vaccine TARGET | FRAME-001 personalized vaccine | Frame Pharmaceuticals B.V. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- FRAME-001 personalized vaccine CI watch — RSS
- FRAME-001 personalized vaccine CI watch — Atom
- FRAME-001 personalized vaccine CI watch — JSON
- FRAME-001 personalized vaccine alone — RSS
Cite this brief
Drug Landscape (2026). FRAME-001 personalized vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/frame-001-personalized-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab